Alternative splicing of PSMD13 mediated by genetic variants is significantly associated with endometrial cancer risk.

Published in: Journal of gynecologic oncology (2023)

are associated with endometrial cancer risk and may be a potential early screening biomarker for endometrial cancer-susceptible populations.

Keyphrases